ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus

December 01, 2009

RICHLAND, Wash. -- Time-lapsed video of individual breast tissue cells reveals a never-before-seen event in the life of a cell: a protein that cycles between two major compartments in the cell. The results give researchers a more complete view of the internal signals that cause breast tissue cells to grow, events that go awry in cancer and are targets of drug development.

The protein ERK, which helps cells respond to growth factors, travels back and forth between the nucleus, where genes are turned on and off, and the cell proper, where proteins work together to keep the cell functioning. In the video, individual cells pulsate with green light as an engineered fluorescent ERK fills the nucleus, exits and re-enters again in cycles that take about 15 minutes. The researchers don't know if the oscillation affects the activity of other proteins in a regulatory fashion, they report in December 1 issue of Molecular Systems Biology, but find the oscillations to be regular and robust.

"True oscillations in biology are rare," said lead author Steve Wiley, chief biologist at EMSL, located at the Department of Energy's Pacific Northwest National Laboratory. "And that the oscillations of such a major growth regulator could go undiscovered for so long is extremely surprising."

ERK As Anchor

One possible function of the oscillations could be in regulating how ERK interacts with other proteins. Regardless of its biological function, ERK oscillations between compartments represent a new behavior that proteins can exhibit within cells.

Biomedical researchers need an accurate mathematical model in hand to test anti-cancer drugs. Adding ERK oscillations into the model allowed Wiley's group to make better predictions about how breast cells will respond to changes in their environment, such as the presence of growth factors or cancer drugs.

"Current models used in drug development behave very differently from the model we came up with," said Wiley. "The oscillations anchored our model in reality."

Round and Round

The meaning of the handful of oscillations found by researchers within cells has been controversial. Calcium levels cycle up and down in nerve cells, but scientists still debate why 20 years after the discovery. The production and destruction of the well-known cancer-related protein p53 continuously cycles, but its purpose is unclear. ERK is one protein in a long chain of command involved in cell growth. Because ERK gets repeatedly activated and deactivated by various proteins, Wiley and colleagues thought it might oscillate.

ERK has a role in human breast tissue, where the molecule epidermal growth factor, or EGF, sends a message from the cell surface to the rest of the cell in a carefully regulated manner that includes ERK. In breast cancer, that chain of command goes awry and cells grow out of control. Cancer drug researchers target players in the chain of command to control that growth.

For that reason, Wiley and his colleagues wanted to better understand EGF's chain of command, also known as its signaling pathway. Most researchers use cancer cells, which are easy to manipulate in culture, but Wiley studied healthy breast tissue to find out what goes on in normal cells. In addition, most research examines the population of cells on average, in which individual differences between cells can get lost. This work watched single cells.

Green Eggs

Researchers know a lot about what activates ERK and what shuts it down in the EGF signaling pathway. To follow ERK, the scientists engineered healthy, cultured breast cells to produce a green-glowing version of the protein. When EGF turns on the signaling pathway, the team verified that the green version of ERK is activated in the same way as the regular version is, by the addition of a chemical group. Other proteins deactivate ERK by removing the chemical group, and the process repeats.

To see what happens in the cells, the team put the culture dishes under a microscope that took pictures automatically once a minute. Then they removed EGF from the cells' culture and let them settle in and quiet down. The cells looked like fried eggs awash in light green.

When the team returned EGF to the culture dishes, the nucleus within cells -- what looks like an egg yolk -- brightened up with green, indicating the ERK proteins were flooding into the nucleus. After a few minutes, the green drained from the nucleus back into the cell proper, only to return again after some time. The oscillations in individual cells cycled about every 15 minutes, starting out in sync but losing that coordination over time.

Also, the time-lapse video showed that cell reproduction didn't seem to affect the cycling. The oscillations continued regularly throughout cell growth. Then the oscillations briefly stopped while one cell divided into two daughter cells. As cell division finished up, the oscillations resumed.

Additional experiments showed the oscillations required EGF in the cell culture and continued for up to ten hours, the longest period of time the researchers observed. In addition, the number of cells with oscillating ERK depended on how crowded the living conditions were. For example, the team found that at the lowest numbers of cells, all of them showed oscillating ERK. As the cells reproduced, fewer cells oscillated. By the time the cells filled the whole surface of their dish, virtually all of the cells lost their cycling ERK.

A Model ERK

One way scientists determine how well they understand the workings of a cell is to see if they can simulate it in a computer program. Wiley and his colleagues developed such a model that included the oscillating ERK, as well as most of the players in the chain of command from EGF receptor on.

To test the model, the team first used the model to predict how the oscillations would behave under conditions that kept ERK activated for a prolonged period of time. The model predicted the oscillations would die out if ERK stayed on. When the team performed a biochemical experiment in which they prevented ERK from de-activating, the percentage of cells oscillating dropped off, as the model predicted.

To further explore the biological significance of the ERK cycles, Wiley's group would like to test whether other growth factors cause ERK to oscillate in breast cells and whether different types of cells exhibit the same sort of oscillations. Ultimately, they would like to know if they can tweak the oscillation to see how things change inside the cell.
-end-
Reference: Harish Shankaran, Danielle L. Ippolito, William B. Chrisler, Haluk Resat, Nikki Bollinger, Lee K. Opresko and H. Steven Wiley, Rapid and Sustained Nuclear-Cytoplasmic ERK Oscillations Induced by Epidermal Growth Factor, Mol Syst Biol, DOI 10.1038/msb.2009.90 (http://www.nature.com/msb/index.html).

This work was supported by PNNL as part of its systems biology initiative and the National Institutes of Health.

EMSL, the Environmental Molecular Sciences Laboratory, is a national scientific user facility sponsored by the Department of Energy's Office of Science, Biological and Environmental Research program that is located at Pacific Northwest National Laboratory. EMSL offers an open, collaborative environment for scientific discovery to researchers around the world. EMSL's technical experts and suite of custom and advanced instruments are unmatched. Its integrated computational and experimental capabilities enable researchers to realize fundamental scientific insights and create new technologies. EMSL's Facebook page.

Pacific Northwest National Laboratory is a Department of Energy Office of Science national laboratory where interdisciplinary teams advance science and technology and deliver solutions to America's most intractable problems in energy, national security and the environment. PNNL employs 4,250 staff, has a $918 million annual budget, and has been managed by Ohio-based Battelle since the lab's inception in 1965. Follow PNNL on Facebook, Linked In and Twitter.

DOE/Pacific Northwest National Laboratory

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.